Moringa concanensis

DOI:

10.1016/j.heliyon.2023.e15607

PubMed:

37305490

Transcriptome profiling of two Moringa species and insights into their antihyperglycemic activity.

Shafi KM et al (2022).

BMC Plant Biol.

DOI:

10.1186/s12870-022-03938-6

PubMed:

36460949

Moringa concanensis L. Alleviates DNCB-Induced Atopic Dermatitis-like Symptoms by Inhibiting NLRP3 Inflammasome-Mediated IL-1β in BALB/c Mice.

Kim KM et al (2022).

Pharmaceuticals (Basel).

DOI:

10.3390/ph15101217

PubMed:

36297328

Moringa concanensis-Mediated Synthesis and Characterizations of Ciprofloxacin Encapsulated into Ag/TiO(2)/Fe(2)O(3)/CS Nanocomposite: A Therapeutic Solution against Multidrug Resistant E. coli Strains of Livestock Infectious Diseases.

Zafar N et al (2022).

Pharmaceutics.

DOI:

10.3390/pharmaceutics14081719

PubMed:

36015345

Photoprotective Potential, Cytotoxicity, and UPLC-QTOF/MS Analysis on Bioactive Solvent Fractions of Moringa concanensis Nimmo Bark.

Santhanam R et al (2022).

Evid Based Complement Alternat Med.

DOI:

10.1155/2022/3781189

PubMed:

35502171

Moringa concanensis Nimmo extracts ameliorates hyperglycemia-mediated oxidative stress and upregulates PPARγ and GLUT4 gene expression in liver and pancreas of streptozotocin-nicotinamide induced diabetic rats.

Balakrishnan BB et al (2019).

Biomed Pharmacother.

DOI:

10.1016/j.biopha.2019.108688

PubMed:

30798121

Moringa concanensis Nimmo ameliorates hyperglycemia in 3T3-L1 adipocytes by upregulating PPAR-γ, C/EBP-α via Akt signaling pathway and STZ-induced diabetic rats.

Balakrishnan BB, Krishnasamy K and Choi KC (2018).

Biomed Pharmacother.

DOI:

10.1016/j.biopha.2018.04.047

PubMed:

29680740

Traditional Medicinal Knowledge on Moringa concanensis Nimmo of Perambalur District, Tamilnadu.

Anbazhakan S et al (2007).

Anc Sci Life.

PubMed:

22557250